The Pediatric PRV Program addressed the market failures we have seen as rare pediatric disease drugs have struggled to market by creating financial incentives for rare pediatric disease drug development in the form of vouchers.
Butterfield advocates for the Pediatric Priority Review Voucher Program to support rare disease drug development.
Share
More from G. K. Butterfield
I listened very carefully to the gentleman from Arkansas, and I respect his position, but I just want to remind my colleagues that in my State and most States these organizations that are not nonprofits who care about the environment and…
Just because you have high turnout doesn't mean that bad laws aren't barriers to voting.
Let's just keep fighting, let's keep pushing, and let's keep representing the people that elect us every 2 years.
I want to remind my friend from Arizona who just spoke that this bill sets uniform national standards for States that choose to require identification to vote. The bill gives States the flexibility--flexibility--to choose whether to…
Other voices in this conversation
